Citius Oncology, Inc. CTOR Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Citius Oncology, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s quick ratio?
- Citius Oncology, Inc. (CTOR) reported quick ratio of 0.1× in Q1 2026.
- How has Citius Oncology, Inc.'s quick ratio changed year-over-year?
- Citius Oncology, Inc.'s quick ratio increased by 111.8% year-over-year, from 0.1× to 0.1×.
- What is the long-term trend for Citius Oncology, Inc.'s quick ratio?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s quick ratio has grown at a -46.2% compound annual growth rate (CAGR), from 0.4× to 0.1×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.